Inducible in vivo genome editing with CRISPR/Cas9

CRISPR-Cas9-based genome editing enables the rapid genetic manipulation of any genomic locus without the need for gene targeting by homologous recombination. Here we describe a conditional transgenic approach that allows temporal control of CRISPR-Cas9 activity for inducible genome editing in adult mice. We show that doxycycline-regulated Cas9 induction enables widespread gene disruption in multiple tissues and that limiting the duration of Cas9 expression or using a Cas9D10A (Cas9n) variant can regulate the frequency and size of target gene modifications, respectively. Further, we show that this inducible CRISPR (iCRISPR) system can be used effectively to create biallelic mutation in multiple target loci and, thus, provides a flexible and fast platform to study loss-of-function phenotypes in vivo.

• Publication year

  2015

• Venue

  Nature Biotechnology

• Publication date

  2015-02-10

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1038/nbt.3155PMID 25690852PMCID 4390466
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Rapid modeling of cooperating genetic events in cancer through somatic genome editing

  2014cited by this paper
• Conditional Reverse Tet-Transactivator Mouse Strains for the Efficient Induction of TRE-Regulated Transgenes in Mice

  2014cited by this paper
• Genome-wide binding of the CRISPR endonuclease Cas9 in mammalian cells

  2014cited by this paper
• An iCRISPR platform for rapid, multiplexable, and inducible genome editing in human pluripotent stem cells.

  2014cited by this paper
• CRISPR-Cas9 knockin mice for genome editing and cancer modeling.

  2014cited by this paper
• In vivo engineering of oncogenic chromosomal rearrangements with the CRISPR/Cas9 system

  2014cited by this paper
• CRISPR-mediated direct mutation of cancer genes in the mouse liver

  2014cited by this paper
• Heritable gene targeting in the mouse and rat using a CRISPR-Cas system

  2013cited by this paper
• Multiplex Genome Engineering Using CRISPR/Cas Systems

  2013cited by this paper
• High frequency off-target mutagenesis induced by CRISPR-Cas nucleases in human cells

  2013cited by this paper
• Double nicking by RNA-guided CRISPR Cas9 for enhanced genome editing specificity.

  2013cited by this paper
• CRISPR-mediated modular RNA-guided regulation of transcription in eukaryotes.

  2013cited by this paper
• One-step generation of mice carrying mutations in multiple genes by CRISPR/Cas-mediated genome engineering.

  2013cited by this paper
• RNA-Guided Human Genome Engineering via Cas9

  2013cited by this paper
• Repurposing CRISPR as an RNA-guided platform for sequence-specific control of gene expression.

  2013cited by this paper
• One-step generation of mice carrying reporter and conditional alleles by CRISPR/Cas-mediated genome engineering.

  2013cited by this paper
• A pipeline for the generation of shRNA transgenic mice

  2012cited by this paper
• A transcription activator-like effector toolbox for genome engineering

  2012cited by this paper
• Long-term expansion of epithelial organoids from human colon, adenoma, adenocarcinoma, and Barrett's epithelium.

  2011cited by this paper
• Resource A Rapid and Scalable System for Studying Gene Function in Mice Using Conditional RNA Interference

  2011cited by this paper
• A limited role for p53 in modulating the immediate phenotype of Apc loss in the intestine

  2008cited by this paper
• Ectopic expression of Oct-4 blocks progenitor-cell differentiation and causes dysplasia in epithelial tissues.

  2005cited by this paper
• Loss of Apc in vivo immediately perturbs Wnt signaling, differentiation, and migration.

  2004cited by this paper
• Homozygosity for the Minallele of Apc results in disruption of mouse development prior to gastrulation

  1995cited by this paper
• Corrections and Clarifications: Multiple Intestinal Neoplasia Caused By a Mutation in the Murine Homolog of the APC Gene

  1992cited by this paper

• The application of experimental models for the drug discovery for digestive tumors.

  2026cites this paper
• Gene Editing Therapies Targeting Lipid Metabolism for Cardiovascular Disease: Tools, Delivery Strategies, and Clinical Progress

  2026cites this paper
• Secreted luciferases as a minimally invasive 3R-compliant tool for accurate monitoring of tumor burden.

  2026cites this paper
• Intracellular metabolic gradients dictate dependence on exogenous pyruvate

  2025cites this paper
• Near-infrared light activatable chemically induced CRISPR system

  2025cites this paper
• Gene Editing: An Effective Tool for the Future Treatment of Kidney Disease

  2025cites this paper
• CRISPR Technology: Transforming the Future of Medicine and Diagnostics

  2025cites this paper
• Controlling CRISPR-Cas9 genome editing in human cells using a molecular glue degrader

  2025cites this paper
• Advances and challenges of CRISPR/Cas gene editing for corneal diseases

  2025cites this paper
• CRISPR Technology in Disease Management: An Updated Review of Clinical Translation and Therapeutic Potential

  2025cites this paper
• Coordinated Tbx3/Tbx5 transcriptional control of the adult ventricular conduction system

  2025cites this paper
• Enhancing Specificity, Precision, Accessibility, Flexibility, and Safety to Overcome Traditional CRISPR/Cas Editing Challenges and Shape Future Innovations

  2025cites this paper
• Sequence-independent optical regulation of CRISPR/Cas editing using star-shaped crRNA dendrimers.

  2025cites this paper
• Animal Models: A Tool for Colon Cancer Research

  2025cites this paper
• Engineered AcrIIA5 for optogenetic control of CRISPR‐Cas9‐based genome editing

  2025cites this paper
• Position-independent single-nucleotide polymorphism discrimination by CRISPR/Cas12a via rational activator strand engineering.

  2025cites this paper
• Manufacturing of CRISPR-edited primary mouse CAR T cells for cancer immunotherapy

  2025cites this paper
• Autologous Production: The Future of Sustainable Antibody Treatments

  2025cites this paper
• Concurrent genetic and non-genetic resistance mechanisms to KRAS inhibition in CRC

  2025cites this paper
• Chemically-inducible CRISPR/Cas9 circuits for ultra-high dynamic range gene perturbation

  2025cites this paper
• Design of an all-in-one drug-inducible CRISPR-based genome editing system and evaluation of its efficacy against a recombinant anti-AChR autoantibody

  2025cites this paper
• Leveraging CRISPR/Cas9 in notable bacteria for the production of industrially valuable compounds

  2025cites this paper
• Development of a CRISPR/Cas9-degron system that enables in vivo specific gene depletion in leukemia models.

  2025cites this paper
• Novel drug-inducible CRISPRa/i systems for rapid and reversible manipulation of gene transcription

  2025cites this paper
• A base editing platform for the correction of cancer driver mutations unmasks conserved p53 transcription programs

  2025cites this paper
• Gene editing in common cardiovascular diseases.

  2024cites this paper
• Coordinated Tbx3/Tbx5 transcriptional control of the adult ventricular conduction system

  2024cites this paper
• rAAV capsid mutants eliminate leaky expression from DNA donor template for homologous recombination

  2024cites this paper
• Recent progress in prompt molecular detection of liquid biopsy using Cas enzymes: innovative approaches for cancer diagnosis and analysis

  2024cites this paper
• Engineered transcription-associated Cas9 targeting in eukaryotic cells

  2024cites this paper
• Using gene or cell therapies to treat Huntington's disease.

  2024cites this paper
• A histone deacetylase, FaSRT1-2, plays multiple roles in regulating fruit ripening, plant growth and stresses resistance of cultivated strawberry.

  2024cites this paper
• CRISPR/Cas9 Gene Editing: A Novel Approach Towards Alzheimer's Disease Treatment.

  2024cites this paper
• Optogenetic and chemogenetic approaches for modeling neurological disorders in vivo.

  2024cites this paper
• Improving CRISPR–Cas9 directed faithful transgene integration outcomes by reducing unwanted random DNA integration

  2024cites this paper
• The new function of FaSRT2-1 protein in energy metabolism: Promoting strawberry fruit quality and ripening.

  2024cites this paper
• CD87-targeted BiTE and CAR-T cells potently inhibit invasive nonfunctional pituitary adenomas

  2024cites this paper
• tsCRISPR based identification of Rab proteins required for the recycling of Drosophila TRPL ion channel

  2024cites this paper
• CAMKV Kinase Signaling Is a Novel Therapeutic Avenue with Prognostic Relevance in Neuroblastoma

  2024cites this paper
• Beyond the promise: evaluating and mitigating off-target effects in CRISPR gene editing for safer therapeutics

  2024cites this paper
• AAV-mediated gene therapies by miniature gene editing tools

  2024cites this paper
• A Simple and Low-Cost CRISPR/Cas9 Knockout System Widely Applicable to Insects

  2024cites this paper
• Genetically-engineered mouse models of small cell lung cancer: the next generation

  2024cites this paper
• The Interplay between Dysregulated Metabolism and Epigenetics in Cancer

  2023cites this paper
• Advances in Making Cancer Mouse Models More Accessible and Informative through Non-Germline Genetic Engineering.

  2023cites this paper
• How CRISPR Is Revolutionizing the Generation of New Models for Cancer Research.

  2023cites this paper
• Regulation of the CRISPR-Cas12a system by methylation and demethylation of guide RNA

  2023cites this paper
• A prime editor mouse to model a broad spectrum of somatic mutations in vivo

  2023cites this paper
• Mechanisms of the Specificity of the CRISPR/Cas9 System in Genome Editing

  2023cites this paper
• Characterising the structural and cellular role of immunoglobulin C-terminal lysine in secretory pathways.

  2023cites this paper
• Establishment, optimization, and application of genetic technology in Aspergillus spp.

  2023cites this paper
• Generation of Brown Fat-Specific Knockout Mice Using a Combined Cre-LoxP, CRISPR-Cas9, and Adeno-Associated Virus Single-Guide RNA System.

  2023cites this paper
• STING inhibits the reactivation of dormant metastasis in lung adenocarcinoma

  2023cites this paper
• A chemically controlled Cas9 switch enables temporal modulation of diverse effectors

  2023cites this paper
• Recent Advances in Genome-Editing Technology with CRISPR/Cas9 Variants and Stimuli-Responsive Targeting Approaches within Tumor Cells: A Future Perspective of Cancer Management

  2023cites this paper
• Doxycycline-dependent Cas9-expressing pig resources for conditional in vivo gene nullification and activation

  2023cites this paper
• Development of a nucleic acid detection method based on the CRISPR-Cas13 for point-of-care testing of bovine viral diarrhea virus-1b

  2023cites this paper
• Unanswered questions in the regulation and function of the duplicated α7 nicotinic receptor gene CHRFAM7A.

  2023cites this paper
• Novel genetically engineered mouse models for clear cell renal cell carcinoma

  2023cites this paper
• The history of genome editing: advances from the interface of chemistry & biology.

  2023cites this paper
• Retrotransposon LINE-1 bodies in the cytoplasm of piRNA-deficient mouse spermatocytes: Ribonucleoproteins overcoming the integrated stress response

  2023cites this paper
• Spatiotemporal Control of Genomics and Epigenomics by Ultrasound

  2023cites this paper
• CRISPR/Cas9-based genome editing for multimodal synergistic cancer nanotherapy

  2023cites this paper
• Ribonucleoprotein condensation driven by retrotransposon LINE-1 sustains RNA integrity and translation in mouse spermatocytes

  2023cites this paper
• Immunogenicity of CRISPR therapeutics—Critical considerations for clinical translation

  2023cites this paper
• Mechanism of the CRISPR/Cas9 System Specificity in Genome Editing

  2023cites this paper
• AAV-based CRISPR-Cas9 genome editing: challenges and engineering opportunities

  2023cites this paper
• X-CHIME enables combinatorial, inducible, lineage-specific and sequential knockout of genes in the immune system

  2023cites this paper
• Cancer variant modeling in vivo

  2023cites this paper
• Delivery of gene editing therapeutics.

  2023cites this paper
• Extracellular vesicles as a potential delivery platform for CRISPR-Cas based therapy in epithelial ovarian cancer.

  2023cites this paper
• A split and inducible adenine base editor for precise in vivo base editing

  2023cites this paper
• Genome editing pig models with elements for controllable gene expression

  2023cites this paper
• Engineered transcription-associated Cas9 targeting in eukaryotic cells

  2023cites this paper
• Multi-scale cellular imaging of DNA double strand break repair.

  2023cites this paper
• Challenges and Future Prospects of CRISPR Technology

  2022cites this paper
• The role of the CRISPR‐Cas system in cancer drug development: Mechanisms of action and therapy

  2022cites this paper
• Leucine retention in lysosomes is regulated by starvation

  2022cites this paper
• Introduction of the FecGF mutation in GDF9 gene via CRISPR/Cas9 system with single-stranded oligodeoxynucleotide.

  2022cites this paper
• CRISPR/Cas9-mediated knock-in strategy at the Rosa26 locus in cattle fetal fibroblasts

  2022cites this paper
• In vivo modeling of CLL transformation to Richter's syndrome reveals convergent evolutionary paths and therapeutic vulnerabilities.

  2022cites this paper
• CRISPR in cancer biology and therapy

  2022cites this paper
• Efficient CRISPR-Cas9-mediated mutagenesis in primary human B cells for identifying plasma cell regulators

  2022cites this paper
• Enzyme-free targeted DNA demethylation using CRISPR–dCas9-based steric hindrance to identify DNA methylation marks causal to altered gene expression

  2022cites this paper
• Small Molecules for Enhancing the Precision and Safety of Genome Editing

  2022cites this paper
• Population-wide gene disruption in the murine lung epithelium via AAV-mediated delivery of CRISPR-Cas9 components

  2022cites this paper
• Engineering of optogenetic devices for biomedical applications in mammalian synthetic biology

  2022cites this paper
• Endogenous spacing enables co-processing of microRNAs and efficient combinatorial RNAi

  2022cites this paper
• Wnt11 in regulation of physiological and pathological cardiac growth

  2022cites this paper
• The Development and Application of Opto-Chemical Tools in the Zebrafish

  2022cites this paper
• SuperFi-Cas9 exhibits extremely high fidelity but reduced activity in mammalian cells

  2022cites this paper
• CRISPR-Cas orthologs and variants

  2022cites this paper
• In Vivo Models for Prostate Cancer Research

  2022influential citation
• Synthetic biology and bioelectrochemical tools for electrogenetic system engineering

  2022cites this paper
• CRISPR-SONIC: targeted somatic oncogene knock-in enables CRISPR-SONIC: targeted somatic oncogene knock-in enables rapid in vivo cancer modeling rapid in vivo cancer modeling Let us know how access to this document benefits you.

  2022cites this paper
• A versatile, chemically-controlled DNA binding switch enables temporal modulation of Cas9-based effectors

  2022cites this paper
• CRISPR-Mediated Activation of αV Integrin Subtypes Promotes Neuronal Differentiation of Neuroblastoma Neuro2a Cells

  2022cites this paper
• Adeno-Associated Virus Toolkit to Target Diverse Brain Cells.

  2022cites this paper
• A dual conditional CRISPR-Cas9 system to activate gene editing and reduce off-target effects in human stem cells

  2022cites this paper
• Bioorthogonally Activatable Base Editing for On-Demand Pyroptosis.

  2022cites this paper